Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041716 | SCV000065412 | likely pathogenic | Rare genetic deafness | 2010-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001386543 | SCV001586804 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 48394). Disruption of this splice site has been observed in individuals with retinitis pigmentosa or Usher syndrome (PMID: 28157192; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 62 of the USH2A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV003445120 | SCV004173916 | likely pathogenic | Usher syndrome type 2A | 2023-04-11 | criteria provided, single submitter | clinical testing |